Literature DB >> 32691829

Neglected Variables in the Interpretation of Serum Procalcitonin Levels in Patients With Septic Shock.

David N Gilbert1.   

Abstract

The interpretation of serum procalcitonin (PCT) levels in septic patients is facilitated by reviewing the known stimuli that activate the PCT family of genes. Herein we describe 7 pathways that, alone or in combination, can increase serum PCT levels. As a marker of activation of innate immunity, high PCT levels affect clinical diagnosis, can be trended as a measure of "source" control, and can guide duration of antibacterial therapy in septic patients. Low PCT levels reflect little to no activation of an innate immune response, influence the differential diagnosis, and support the discontinuation of empiric antibiotic therapy. Understanding the pathways that result in elevated serum PCT levels is necessary for interpretation and subsequent clinical management.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Procalcitonin; sepsis; shock

Year:  2020        PMID: 32691829     DOI: 10.1093/infdis/jiaa204

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel.

Authors:  David N Gilbert; James E Leggett; Lian Wang; Shirin Ferdosian; Gita D Gelfer; Michael L Johnston; Brent W Footer; Kathryn W Hendrickson; Hiromichi S Park; Emma E White; John Heffner
Journal:  Diagn Microbiol Infect Dis       Date:  2020-10-16       Impact factor: 2.803

2.  Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.

Authors:  Natalie J Atallah; Hailey M Warren; Matthew B Roberts; Ramy H Elshaboury; Monique R Bidell; Ronak G Gandhi; Meagan Adamsick; Maryam K Ibrahim; Rupali Sood; Savo Bou Zein Eddine; Matthew J Cobler-Lichter; Natalie J Alexander; Kyle D Timmer; Christine J Atallah; Adam L Viens; Vahe S Panossian; Allison K Scherer; Teddie Proctor; Sherrie Smartt; Alyssa R Letourneau; Molly L Paras; Sascha Johannes; Jan Wiemer; Michael K Mansour
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

3.  Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study.

Authors:  Amal A Gharamti; Fei Mei; Katherine C Jankousky; Jin Huang; Peter Hyson; Daniel B Chastain; Jiawei Fan; Sharmon Osae; Wayne W Zhang; José G Montoya; Kristine M Erlandson; Sias J Scherger; Carlos Franco-Paredes; Andrés F Henao-Martínez; Leland Shapiro
Journal:  medRxiv       Date:  2020-10-22

4.  Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.

Authors:  Amal A Gharamti; Fei Mei; Katherine C Jankousky; Jin Huang; Peter Hyson; Daniel B Chastain; Jiawei Fan; Sharmon Osae; Wayne W Zhang; José G Montoya; Kristine M Erlandson; Sias J Scherger; Carlos Franco-Paredes; Andrés F Henao-Martínez; Leland Shapiro
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.